Canada continues to approve and sell the highest-selling internationally approved new medicines – PMPRB’s latest report
The Patented Medicine Prices Review Board (PMPRB) published the 10th edition of its annual Meds Entry Watch report today.
Cancele cuando quiera · 99 CA$/mes


